Andrew Aukerman

Andrew Aukerman

Auto-generated profile, based on publicly available information

Andrew Aukerman

Memorial Sloan Kettering Cancer Center 3 Department of Epidemiology and Biostatistics New York, New York

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Nature Cancer
Verified
Journal Article
Open access
PDF file
RVRami S. Vanguri
Rami S. Vanguri
JLJia Luo
Jia Luo
AAAndrew T. Aukerman
Andrew T. Aukerman
JEJacklynn V. Egger
Jacklynn V. Egger
CFChristopher J. Fong
Christopher J. Fong
SSSohrab P. Shah
Sohrab P. Shah
Immunotherapy is used to treat almost all patients with advanced non-small cell lung cancer (NSCLC); however, identifying robust predictive biomarkers remains challenging. Here we show the predictive capacity of integrating medical imaging, histopathologic and genomic features to predict immunotherapy response using a cohort of 247 patients with advanced NSCLC with multimodal baseline data obtained during diagnostic clinical workup, including computed tomography scan images, digitized programmed death ligand-1 immunohistochemistry slides and known outcomes to immunotherapy. Using domain expert annotations, we developed a computational workflow to extract patient-level features and used a machine-learning approach to integrate multimodal features into a risk prediction model. Our multimodal model (area under the curve (AUC) = 0.80, 95% confidence interval (CI) 0.74–0.86) outperformed unimodal measures, including tumor mutational burden (AUC = 0.61, 95% CI 0.52–0.70) and programmed death ligand-1 immunohistochemistry score (AUC = 0.73, 95% CI 0.65–0.81). Our study therefore provides a quantitative rationale for using multimodal features to improve prediction of immunotherapy response in patients with NSCLC using expert-guided machine learning.

17 June 2026
Verified
Other
Open access
SSSandeep K Singhal
Sandeep K Singhal
CLChen Li
Chen Li
AAAndrew Aukerman
Andrew Aukerman
MCMathieu Carrière
Mathieu Carrière
MMMichael L Miller
Michael L Miller
KGKevin L. Gardner
Kevin L. Gardner
Loss of organized structure is a hallmark of malignant transformation in breast cancer. Traditionally, such morphologic features are captured by descriptive histologic assessments, such as grade, that represent reliable diagnostic and prognostic determinants. Nonetheless, the predictive value of these semiquantitative approaches is limited by their subjective nature and the computational restrictions inherent to discrete integer-based scoring systems. In this study, we describe an application of topological measurements and statistical modeling to derive continuous mathematical scores that quantitatively reflect the level of organized structure within human breast cancer tissues. This approach generated quantifiable biomarkers, assessable on a continuous scale, that predicted breast cancer survival. Compared with traditional biomarkers, these topology-based measurements showed higher prognostic accuracy with less variation associated with race and ethnicity. Integration of these biomarkers with gene expression data produced topology-derived gene signatures that predicted therapeutic response and uncovered gene regulatory networks linking metabolism with the breast cancer tumor microenvironment in racially diverse breast cancer cohorts. Overall, this study demonstrates the potential of spatial and topological biomarkers in breast cancer treatment and diagnosis. Application and adaptation of methods that quantify tumor architectural features to develop prognostic and predictive algorithms exemplify the immense future promise of defining linkages among biology, medicine, and mathematics.Significance:Topological features of breast cancer histology can be quantified on a continuous scale and used to accurately predict breast cancer patient survival and response to therapy.

9 February 2026 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SSSandeep K Singhal
Sandeep K Singhal
CLChen Li
Chen Li
AAAndrew Aukerman
Andrew Aukerman
MCMathieu Carrière
Mathieu Carrière
MMMichael L Miller
Michael L Miller
KGKevin L. Gardner
Kevin L. Gardner
Loss of organized structure is a hallmark of malignant transformation in breast cancer. Traditionally, such morphologic features are captured by descriptive histologic assessments, such as grade, that represent reliable diagnostic and prognostic determinants. Nonetheless, the predictive value of these semiquantitative approaches is limited by their subjective nature and the computational restrictions inherent to discrete integer-based scoring systems. In this study, we describe an application of topological measurements and statistical modeling to derive continuous mathematical scores that quantitatively reflect the level of organized structure within human breast cancer tissues. This approach generated quantifiable biomarkers, assessable on a continuous scale, that predicted breast cancer survival. Compared with traditional biomarkers, these topology-based measurements showed higher prognostic accuracy with less variation associated with race and ethnicity. Integration of these biomarkers with gene expression data produced topology-derived gene signatures that predicted therapeutic response and uncovered gene regulatory networks linking metabolism with the breast cancer tumor microenvironment in racially diverse breast cancer cohorts. Overall, this study demonstrates the potential of spatial and topological biomarkers in breast cancer treatment and diagnosis. Application and adaptation of methods that quantify tumor architectural features to develop prognostic and predictive algorithms exemplify the immense future promise of defining linkages among biology, medicine, and mathematics. Significance: Topological features of breast cancer histology can be quantified on a continuous scale and used to accurately predict breast cancer patient survival and response to therapy.

17 June 2026
Verified
Other
Open access
PDF file
SSSandeep K Singhal
Sandeep K Singhal
CLChen Li
Chen Li
AAAndrew Aukerman
Andrew Aukerman
MCMathieu Carrière
Mathieu Carrière
MMMichael L Miller
Michael L Miller
KGKevin L. Gardner
Kevin L. Gardner
Topology-based Spatial Biomarkers predict patient response to neoadjuvant chemotherapy in breast cancer clinical trials

17 June 2026
Verified
Other
Open access
PDF file
SSSandeep K Singhal
Sandeep K Singhal
CLChen Li
Chen Li
AAAndrew Aukerman
Andrew Aukerman
MCMathieu Carrière
Mathieu Carrière
MMMichael L Miller
Michael L Miller
KGKevin L. Gardner
Kevin L. Gardner
Respresentative samples demonstrating range of PD-L1 intensities

17 June 2026
Verified
Other
Open access
PDF file
SSSandeep K Singhal
Sandeep K Singhal
CLChen Li
Chen Li
AAAndrew Aukerman
Andrew Aukerman
MCMathieu Carrière
Mathieu Carrière
MMMichael L Miller
Michael L Miller
KGKevin L. Gardner
Kevin L. Gardner
Comparison of predictive values (C-index, survival) of different spatial features and input data